Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-11-21 17:29:22
Reporting Period:
Accepted Time:
2017-11-21 17:29:22
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615764 Iain Mcgill 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Svp, Europe & Rest Of World No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2017-11-17 8,000 $46.83 28,383 No 4 M Direct
Ordinary Shares Disposition 2017-11-17 8,000 $133.42 20,383 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-Qualified Stock Option (right to buy) Disposition 2017-11-17 8,000 $133.42 8,000 $46.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,500 2022-08-08 No 4 M Direct
  1. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $132.95 to $133.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  2. This non-qualified stock option was granted on August 9, 2012 and vested over a period four years from date of grant. The options were fully vested as of August 9, 2016.